Acceptability of mifepristone for early pregnancy interruption.
D000028:Abortion, Induced; D001290:Attitude; D002140:California; D018864:Cultural Diversity; D003906:Developing Countries; D004345:Drug Industry; D005260:Female; D005602:France; D005610:Freedom; D013502:General Surgery; D006801:Humans; D007391:International Cooperation; D038622:Internationality; D015735:Mifepristone; D010358:Patient Participation; D010361:Patients; D026684:Personal Autonomy; D004364:Pharmaceutical Preparations; D010919:Placebos; D011247:Pregnancy; D037841:Pregnant People; D018907:Privacy; D011640:Public Policy; D011897:Random Allocation; D012106:Research; D012306:Risk; D018570:Risk Assessment; D012926:Social Control, Formal; D012945:Social Values; D036302:Therapeutic Human Experimentation; D006113:United Kingdom; D014930:Women; D014932:Women's Health Services
Genetics and Reproduction; Roussel Uclaf